Conversely, elevated levels of PLPP2 have been observed in many cancers, including liver and prostate [41], breast [42] and renal cell cancer [43], which was opposite to the expression pattern of PLPP1 and PLPP3. This evidence concerns the gene PLPP1 and renal cell adenocarcinoma.